Study confirms validity of data from internet-recruited patients
Quintiles' latest study could pave the way for more direct-to-patient studies using patient-reported outcomes combined with medical record data.
A study has confirmed the reliability of data collected via patients who are recruited over the internet for the purpose of observational studies.
The internet provides a useful source of patients, who can be recruited, screened and enrolled online without physical contact.
Now, the latest study from Quintiles' Digital Patient Unit (DPU) has confirmed that patient-reported outcomes collected from participants recruited in this way are indeed reliable.
This means trial leaders can perform observational research that combines patient-reported outcomes and medical record data without worrying about the reliability of their results.
Elisa Cascade, vice-president of Quintiles' DPU and co-author of the study in the Journal of Medical Internet Research, said the results were "positive".
She revealed: "This pilot validates the use of patient-reported outcomes when collected in this manner. It is a foundational step toward broader use of this design in collecting real-world, observational data."
Dr Rich Gliklich, president of Quintiles Outcomes, added that direct-to-patient studies will become "increasingly important", given the widespread demand for rapid data collection.
Related News
-
News Pfizer forges ahead with blood cancer therapy after approval from FDA
Pfizer gains accelerated approval from the US FDA for their new bispecific antibody therapy for multiple myeloma, set to address an unmet need for patients. -
News Alzheimer's drug donanemab deemed effective in landmark clinical trial
Results from the TRAILBLAZER-ALZ 2 Randomised Clinical Trial into the use of donanemab to treat early symptoms of Alzheimer’s disease have been analysed. -
News PSCI launches progressive position on the use of Horseshoe Crabs
A quarterly series of articles about responsible supply chain management from the PSCI. -
News Delivering on mRNA-based therapeutics: innovations in applications and packaging
Since the onset of the COVID-19 pandemic, the innovative potential of mRNA vaccines and therapeutics has raised questions regarding their manufacturing, packaging, and storage/transportation. Learn about how the pharmaceutical supply chain is meet... -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute. -
News Novavax will provide adjuvant Matrix-M for vaccine research with 3-year partnership
Novavax, developers behind the Matrix-M adjuvant, have entered into an agreement with the Bill and Melinda Gates Medical Research Institute to provide the adjuvant in preclinical vaccine research. -
News Thermo Fisher Scientific opens new steriles drug manufacturing site in Singapore
The life science service and instrument provider have opened their new Singapore-based steriles drug manufacturing facility with the goal of bringing increased development and manufacturing capabilities for critical medicines to the APAC region. -
News Medicines for All receive $18.7 million grant for expansion of global access to lifesaving medication
Funded by the Bill & Melinda Gates Foundation, the Virginia Commonwealth University-based research-related institute will use the grant to expand on its current capabilities of bringing lifesaving medications around the world, as well as working on 14 ...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance